One in 4 patients who visited emergency department for chest pain did not receive follow-up care

Patients with multiple health issues and who are at higher risk of adverse events are less likely to receive follow-up care from a physician after visiting an emergency department for chest pain, reports a study published in CMAJ(Canadian Medical Association Journal).Chest pain is one of the most common reasons people visit emergency departments, with about 500 000 visits every year in Canada alone.The study looked at 56 767 patients with chest pain who visited an emergency department in Ontario between April 2004 and March 2010. Of these, 42 535 (75%) were seen by a primary care physician or cardiologist within 30 days after discharge, and 14 232 (25%) did not receive follow-up care. Patients with multiple illnesses such as heart disease, kidney disease and dementia, and rural residency were less likely than others to receive follow-up care in the following month. Patients who had visited a primary care physician or cardiologist in the preceding year were more likely to see a physician after discharge.”We initially thought that emergency department physicians would risk stratify patients such that those with more medical and cardiac comorbidities would receive more physician follow-up care,” writes Dr. Dennis Ko, a senior scientist at the Institute for Clinical Evaluative Sciences (ICES) and an interventional cardiologist at the Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, with coauthors. “However, patients with more medical comorbidities in our cohort were less likely to receive physician follow-up postdischarge.”

Read the rest of the article at  http://www.medicalnewstoday.com/releases/289784.php.

Novel peptide shows promise in penetrating heart attack scar tissue to regenerate cardiac nerves and avert dangerous arrhythmias

Case Western Reserve’s chemical compound aimed at restoring spinal cord function may have an additional purpose: stopping potentially fatal arrhythmias after heart attack.Case Western Reserve neurosciences professor Jerry Silver, PhD, long has believed that lessons learned over decades from spinal cord research could someday apply to other areas of the body. He got the chance to test his theory when a colleague from another campus realized that his new compound – intracellular sigma peptide (ISP) – could address a critical cardiac issue.The results of the project, led by Oregon Health & Sciences University (OHSU) researcher Beth A. Habecker, PhD, exceeded even Silver’s greatest hopes: 100 percent success in animal models. Details can be found in Nature Communication.”Essentially, the OHSU group cured arrhythmia in the mouse using ISP,” Silver said. “They observed true regeneration right back into the scar within the infarct area. This is pretty exciting.”

Read the rest of the article at http://www.medicalnewstoday.com/releases/289007.php.